Latest Breaking News On - Earnings history for impel pharmaceuticals - Page 1 : comparemela.com

Impel Pharmaceuticals (NASDAQ:IMPL – Get Rating) is scheduled to release its earnings data before the market opens on Friday, May 12th. Impel Pharmaceuticals Stock Up 12.6 % NASDAQ IMPL opened at $2.60 on Friday. The company has a market capitalization of $61.75 million, a P/E ratio of -0.57 and a beta of -0.26. Impel Pharmaceuticals […]

United statesNews ratings for impel pharmaceuticals dailyInstitutional trading of impel pharmaceuticalsImpel pharmaceuticalsGoldman sachs group incImpel pharmaceuticals stockEarnings history for impel pharmaceuticalsCitadel advisorsTower research capitalImpel pharmaceuticals incRaymond james associatesGet ratingStreet groupResearch capitalGoldman sachs groupSachs group